GB201114923D0 - Immunogenic proteins and compositions - Google Patents

Immunogenic proteins and compositions

Info

Publication number
GB201114923D0
GB201114923D0 GB201114923A GB201114923A GB201114923D0 GB 201114923 D0 GB201114923 D0 GB 201114923D0 GB 201114923 A GB201114923 A GB 201114923A GB 201114923 A GB201114923 A GB 201114923A GB 201114923 D0 GB201114923 D0 GB 201114923D0
Authority
GB
United Kingdom
Prior art keywords
compositions
immunogenic proteins
streptococcus
proteins
gbs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201114923A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB201114923A priority Critical patent/GB201114923D0/en
Publication of GB201114923D0 publication Critical patent/GB201114923D0/en
Application status is Ceased legal-status Critical

Links

Abstract

The invention provides proteins and compositions for the treatment and prevention of Streptococcus agalactiae (Group B streptococcus; GBS).
GB201114923A 2011-08-30 2011-08-30 Immunogenic proteins and compositions Ceased GB201114923D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201114923A GB201114923D0 (en) 2011-08-30 2011-08-30 Immunogenic proteins and compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201114923A GB201114923D0 (en) 2011-08-30 2011-08-30 Immunogenic proteins and compositions
PCT/IB2012/054464 WO2013030783A1 (en) 2011-08-30 2012-08-30 Immunogenic proteins and compositions

Publications (1)

Publication Number Publication Date
GB201114923D0 true GB201114923D0 (en) 2011-10-12

Family

ID=44838893

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201114923A Ceased GB201114923D0 (en) 2011-08-30 2011-08-30 Immunogenic proteins and compositions

Country Status (2)

Country Link
GB (1) GB201114923D0 (en)
WO (1) WO2013030783A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108064174A (en) * 2014-08-05 2018-05-22 葛兰素史密丝克莱恩生物有限公司 The carrier molecule of antigen

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5916588A (en) 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US4882317A (en) 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IT1187753B (en) 1985-07-05 1987-12-23 Sclavo Spa Glycoprotein conjugate to attivita 'trivalent immunogenic
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
NL8802046A (en) 1988-08-18 1990-03-16 Gen Electric A polymer mixture with polyester, and paraffin sulfonate, articles formed therefrom.
AU631377B2 (en) 1988-08-25 1992-11-26 Liposome Company, Inc., The Affinity associated vaccine
DE3841091A1 (en) 1988-12-07 1990-06-13 Behringwerke Ag Synthetic antigenic, process for their production and their use
DE68907045D1 (en) 1989-01-17 1993-07-15 Eniricerche Spa Synthetic peptides and their use as a general carrier for the preparation of immunogenic conjugates that are suitable for the development of synthetic vaccines.
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
AU651949B2 (en) 1989-07-14 1994-08-11 American Cyanamid Company Cytokine and hormone carriers for conjugate vaccines
IT1237764B (en) 1989-11-10 1993-06-17 Eniricerche Spa Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use for the development of synthetic vaccines.
GB2276169A (en) 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
SE466259B (en) 1990-05-31 1992-01-20 Arne Forsgren Protein D - an IgD-binding protein FROM Haemophilus influenzae, and anvaendning this Foer analysis, vaccines and uppreningsaendamaal
IL98715D0 (en) 1990-08-13 1992-07-15 American Cyanamid Co Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
IT1262896B (en) 1992-03-06 1996-07-22 Compounds conjugates formed by heat shock proteins (hsp) poly- and oligo-saccharides, their use for the production of vaccines.
DK0671948T3 (en) 1992-06-25 1997-09-01 Smithkline Beecham Biolog A vaccine composition containing adjuvants
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
DK0812593T4 (en) 1993-03-23 2008-05-13 Smithkline Beecham Biolog Vaccine preparations containing 3-O-deacylated monophosphoryl lipid-A
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
GB9513261D0 (en) 1995-06-29 1995-09-06 Smithkline Beecham Biolog Vaccines
US5707829A (en) 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
WO1998040100A1 (en) 1997-03-10 1998-09-17 Ottawa Civic Loeb Research Institute USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
GB9712347D0 (en) 1997-06-14 1997-08-13 Smithkline Beecham Biolog Vaccine
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
ES2201551T3 (en) 1997-09-05 2004-03-16 Glaxosmithkline Biologicals S.A. Oil in water emulsions containing saponins.
GB9725084D0 (en) 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
AU759391B2 (en) 1998-02-12 2003-04-10 Wyeth Holdings Corporation Pneumococcal and meningococcal vaccines formulated with interleukin-12
US7018637B2 (en) 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
US6303114B1 (en) 1998-03-05 2001-10-16 The Medical College Of Ohio IL-12 enhancement of immune responses to T-independent antigens
HU0101619A3 (en) 1998-04-09 2003-11-28 Smithkline Beecham Biolog Adjuvant compositions
HU0103100A3 (en) 1998-08-19 2005-11-28 Baxter Healthcare Sa Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
WO2000033882A1 (en) 1998-12-04 2000-06-15 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services A vi-repa conjugate vaccine for immunization against salmonella typhi
EP1880735A3 (en) 1999-03-19 2008-03-12 GlaxoSmithKline Biologicals S.A. Vaccine
CA2365914A1 (en) 1999-04-09 2000-10-19 Techlab, Inc. Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
GB0007432D0 (en) 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
ES2335979T3 (en) 2001-09-14 2010-04-07 Cytos Biotechnology Ag Immunostimulator cpg packaging in virus similar particles: preparation method and its use.
JP4360906B2 (en) 2001-09-14 2009-11-11 サイトス バイオテクノロジー アーゲー In vivo activation of antigen-presenting cells to enhance the immune response induced by virus-like particles
CA2537742C (en) * 2003-09-15 2014-07-22 Chiron Corporation Immunogenic compositions for streptococcus agalactiae
MXPA05014016A (en) 2003-06-23 2006-03-17 Baxter Int Carrier proteins for vaccines.
WO2006078318A2 (en) * 2004-07-29 2006-07-27 Novartis Vaccines And Diagnostics Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
CN101107010A (en) 2004-11-01 2008-01-16 布里格海姆妇女医院公司 Modified streptococcal polysaccharides and uses thereof
GB0502096D0 (en) 2005-02-01 2005-03-09 Chiron Srl Purification of streptococcal capsular polysaccharide
EP1919934A2 (en) 2005-05-13 2008-05-14 Novartis Vaccines and Diagnostics, Inc. Serum resistance factors of gram positive bacteria
EA012528B1 (en) 2005-06-27 2009-10-30 Глаксосмитклайн Байолоджикалс С.А. Immunogenic composition
WO2009027768A2 (en) * 2006-07-26 2009-03-05 Novartis Ag Immunogenic compositions for gram positive bacteria
GB0802503D0 (en) 2008-02-11 2008-03-19 Novartis Ag Hybrid polypeptide
EP2385842A1 (en) * 2009-01-12 2011-11-16 Novartis AG Cna_b domain antigens in vaccines against gram positive bacteria
GB201003333D0 (en) * 2010-02-26 2010-04-14 Novartis Ag Immunogenic proteins and compositions

Also Published As

Publication number Publication date
WO2013030783A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
HUE040211T2 (en) Microbiota restoration therapy (mrt), compositions and methods of manufacture
EA201491486A1 (en) Derivatives of piperidinopyrimidine for the treatment of viral infections
MX2014010455A (en) Methods and compositions for treating huntington's disease.
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
MX2015001829A (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases.
MX362550B (en) Heterocyclic inhibitors of glutaminase.
EA201390803A1 (en) Bromodomain inhibitors and their use
PH12015501483B1 (en) Heterocyclic compounds and uses thereof
PH12015501648A1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
UA104005C2 (en) 2-oxo-1,2-dihydro-quinoline modulators of immune function
PH12014501844A1 (en) Peptidomimetic macrocycles
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
MX2015004771A (en) Methods of treating cancer.
MX2014014196A (en) Lipid-coated albumin nanoparticle compositions and methods of making and method of using the same.
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
GB201106750D0 (en) Novel compounds
MX2013001748A (en) Peptidomimetic macrocycles.
MX2014013549A (en) TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE.
MX2015011897A (en) Prodrugs of fumarates and their use in treating various deseases.
MX2012011892A (en) Method of treating obesity using antioxidant inflammation modulators.
MX2015001601A (en) Methods of treating a tauopathy.
TN2012000414A1 (en) Forms of rifaximin and uses thereof
MX2013015311A (en) Pcsk9-binding polypeptides and methods of use.
MX2013011479A (en) Anti-fgfr4 antibodies and methods of use.
MX2015011898A (en) Pyrazolo compounds and uses thereof.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)